GIBQ-002 · GIBQ Verified Seal Usage Policy v1.0 · April 2026
Policy Document · GIBQ-002
GIBQ Verified Seal Usage Policy
Authorized and prohibited uses of the GIBQ Verified certification mark
GIBQ-002
1.0
April 2026
Active
GIBQ — Global Institute for Biomedical Quality
1. Purpose
This policy governs the authorized use of the GIBQ Verified certification mark (the “Seal”) by vendors who have received a valid GIBQ Certificate of Verification. The Seal is a registered certification mark of the Global Institute for Biomedical Quality and may only be used in accordance with this policy.
The integrity of GIBQ certification depends on consistent, accurate use of the Seal. Misuse — including use by uncertified vendors or use that misrepresents the scope of certification — undermines the trust that the GIBQ program is designed to establish.
2. The GIBQ Verified Seal
GIBQ Verified MarkThe Seal consists of the GIBQ shield device accompanied by the text “GIBQ Verified” and the associated certificate number. The Seal may be displayed as provided in the GIBQ Brand Kit or as reproduced from an official GIBQ certificate.
3. Authorized Uses
A vendor holding a valid, current GIBQ Certificate of Verification is authorized to use the Seal in the following ways:
On product pages and listings for the specific certified SKUs identified in the certificate
In marketing materials, including email communications and digital advertising, provided the certificate number is displayed alongside the Seal
On physical product packaging for certified lots, accompanied by the certificate number and certification date
On the vendor's website to indicate GIBQ Verified status, with a link to the GIBQ Registry entry
In press releases and media communications announcing or referencing the certification
In all authorized uses, the certificate number (format: GIBQ-YYYY-NNN) must be displayed in proximity to the Seal. The Seal may not be used without this reference.
4. Prohibited Uses
Use by uncertified vendors. Any vendor that has not received a current, valid GIBQ Certificate of Verification is strictly prohibited from displaying the Seal or any representation of it.
Use for uncertified SKUs. The Seal may not be displayed on product pages or packaging for products not listed in the vendor's current certificate.
Use after certificate expiry or revocation. Vendors must remove all Seal displays within 30 days of certificate expiry or immediately upon revocation.
Modification of the Seal. The Seal may not be altered, recolored, distorted, or combined with other marks in a way that changes its appearance or implies an endorsement beyond the scope of GIBQ certification.
Implying regulatory approval. The Seal certifies independent audit conformance only. It may not be used in a manner that implies FDA approval, pharmaceutical-grade classification, or any regulatory authorization.
Use in connection with human consumption claims. GIBQ certifies research peptide products for research use only. The Seal may not be used in any context that promotes or implies human consumption.
5. Reporting Misuse
Any party who observes suspected misuse of the GIBQ Verified Seal — including use by uncertified vendors or fraudulent display — is encouraged to report it to GIBQ at info@gibq.org with the subject line “Seal Misuse Report.” GIBQ will investigate all reports and take appropriate action, which may include public notice of misuse and legal action where warranted.
6. Enforcement
GIBQ reserves the right to revoke certification and demand immediate cessation of Seal use by any vendor found to be in violation of this policy. GIBQ may pursue legal remedies available under trademark law for unauthorized use of the certification mark.
Vendors who believe they have received a notice in error may appeal in writing to info@gibq.org within 14 days of receiving notice.
7. Contact
Questions regarding authorized use of the GIBQ Verified Seal should be directed to:
Global Institute for Biomedical Quality 70 Middle Neck Road, Suite 5, Great Neck, NY 11021 info@gibq.org
8. Revision History
Version
Date
Summary
1.0
April 2026
Initial publication.
Issued by: Global Institute for Biomedical Quality